INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 32
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Ascend Medical

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Whole-person care: physicians, health coaches, therapists; 'Starting at $150'; in-network insurance; NPS 97 claim.

Audienceread

READ: insured adults wanting full-care-team approach, emotional-eating/behavior support; Georgia roots.

Pricing & termspartial

Starting packages: semaglutide $225, tirzepatide $240 (title says from $150); insurance-dependent.

Clinical relationshipspartial

Ascend's own in-network physicians/PAs (PAs named in consent); no separate MSO/PC entity named in text read.

Pharmacy & fulfillmentnot_found

Pharmacy not named in pages read.

Advertising snapshotsnapshot

Meta US active exact-phrase keyword: ~4 results. Google US last-30-days domain search: 46 ads. Sample last shown Oct 11, 2026.

Founding yearverified

2020 (launched care model in metro Atlanta).

Foundersverified

Jason Madsen, Founder & CEO (also founded Well Street Urgent Care).

Location & entity contextpartial

Metro Atlanta, Georgia (about page).

Search visibility samplesnapshot

Free domain-restricted search returned 15 result(s) in a bounded sample, not an indexed-page count; top pages listed in sources. No rank/traffic data (paid analytics excluded).

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.